Effects of intravenous endralazine in essential hypertension.

The effects of endralazine, administered intravenously, on blood pressure, heart rate, forearm blood flow, plasma renin activity, aldosterone, adrenaline and noradrenaline were studied in five patients with essential hypertension. Endralazine reduced peripheral vascular resistance, resulting in decrease in mean arterial pressure from 141 to 116 mm Hg and increase in heart rate from 67 to 92 beats/min. Plasma renin activity, adrenaline and noradrenaline increased significantly after endralazine infusion. All effects observed are consistent with endralazine acting as a peripheral vasodilating drug.
AuthorsJ J Hoffmann, T Thien, A van T'Laar
JournalBritish journal of clinical pharmacology (Br J Clin Pharmacol) Vol. 16 Issue 1 Pg. 39-44 (Jul 1983) ISSN: 0306-5251 [Print] England
PMID6349669 (Publication Type: Journal Article)
Chemical References
  • Antihypertensive Agents
  • Pyridazines
  • BQ 22-708
  • Aldosterone
  • Renin
  • Norepinephrine
  • Epinephrine
  • Adult
  • Aldosterone (blood)
  • Antihypertensive Agents (administration & dosage, adverse effects)
  • Blood Pressure (drug effects)
  • Epinephrine (blood)
  • Female
  • Humans
  • Hypertension (drug therapy)
  • Male
  • Middle Aged
  • Norepinephrine (blood)
  • Pyridazines (administration & dosage, adverse effects)
  • Renin (blood)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!

Choose Username:
Verify Password:
Enter Code Shown: